Wangsu Science & Technology Co.,Ltd.

SZSE:300017 Voorraadrapport

Marktkapitalisatie: CN¥21.9b

Wangsu Science & TechnologyLtd Toekomstige groei

Future criteriumcontroles 1/6

Wangsu Science & TechnologyLtd zal naar verwachting groeien in winst en omzet met respectievelijk 13.8% en 7.8% per jaar. De winst per aandeel zal naar verwachting groeien met 13.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 7.3% zijn.

Belangrijke informatie

13.8%

Groei van de winst

13.8%

Groei van de winst per aandeel

IT winstgroei33.2%
Inkomstengroei7.8%
Toekomstig rendement op eigen vermogen7.3%
Dekking van analisten

Good

Laatst bijgewerkt11 Nov 2024

Recente toekomstige groei-updates

Wangsu Science & Technology Co.,Ltd. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next

Apr 17
Wangsu Science & Technology Co.,Ltd. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next

Recent updates

We Like These Underlying Return On Capital Trends At Wangsu Science & TechnologyLtd (SZSE:300017)

Nov 23
We Like These Underlying Return On Capital Trends At Wangsu Science & TechnologyLtd (SZSE:300017)

Wangsu Science & TechnologyLtd's (SZSE:300017) Profits Appear To Have Quality Issues

Nov 01
Wangsu Science & TechnologyLtd's (SZSE:300017) Profits Appear To Have Quality Issues

Wangsu Science & Technology Co.,Ltd.'s (SZSE:300017) 30% Share Price Surge Not Quite Adding Up

Sep 30
Wangsu Science & Technology Co.,Ltd.'s (SZSE:300017) 30% Share Price Surge Not Quite Adding Up

Here's Why We Think Wangsu Science & TechnologyLtd (SZSE:300017) Is Well Worth Watching

Sep 22
Here's Why We Think Wangsu Science & TechnologyLtd (SZSE:300017) Is Well Worth Watching

We Think Wangsu Science & TechnologyLtd (SZSE:300017) Can Manage Its Debt With Ease

Sep 06
We Think Wangsu Science & TechnologyLtd (SZSE:300017) Can Manage Its Debt With Ease

Some Investors May Be Worried About Wangsu Science & TechnologyLtd's (SZSE:300017) Returns On Capital

Jul 01
Some Investors May Be Worried About Wangsu Science & TechnologyLtd's (SZSE:300017) Returns On Capital

With EPS Growth And More, Wangsu Science & TechnologyLtd (SZSE:300017) Makes An Interesting Case

Jun 13
With EPS Growth And More, Wangsu Science & TechnologyLtd (SZSE:300017) Makes An Interesting Case

Is Wangsu Science & TechnologyLtd (SZSE:300017) A Risky Investment?

May 22
Is Wangsu Science & TechnologyLtd (SZSE:300017) A Risky Investment?

We Think That There Are Some Issues For Wangsu Science & TechnologyLtd (SZSE:300017) Beyond Its Promising Earnings

Apr 19
We Think That There Are Some Issues For Wangsu Science & TechnologyLtd (SZSE:300017) Beyond Its Promising Earnings

Wangsu Science & Technology Co.,Ltd. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next

Apr 17
Wangsu Science & Technology Co.,Ltd. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next

These Return Metrics Don't Make Wangsu Science & TechnologyLtd (SZSE:300017) Look Too Strong

Mar 21
These Return Metrics Don't Make Wangsu Science & TechnologyLtd (SZSE:300017) Look Too Strong

Unpleasant Surprises Could Be In Store For Wangsu Science & Technology Co.,Ltd.'s (SZSE:300017) Shares

Feb 27
Unpleasant Surprises Could Be In Store For Wangsu Science & Technology Co.,Ltd.'s (SZSE:300017) Shares

Winst- en omzetgroeiprognoses

SZSE:300017 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20265,7688346259055
12/31/20255,3617313857687
12/31/20245,0266343927987
9/30/20244,798616671828N/A
6/30/20244,679652483632N/A
3/31/20244,657657878982N/A
12/31/20234,705613705792N/A
9/30/20234,8644411,0041,068N/A
6/30/20234,8773621,1081,235N/A
3/31/20235,0212348501,010N/A
1/1/20235,084191743932N/A
9/30/20225,062199652905N/A
6/30/20225,054161339548N/A
3/31/20224,769175324513N/A
1/1/20224,575165581836N/A
9/30/20214,482153514771N/A
6/30/20214,675134502777N/A
3/31/20215,1591756261,025N/A
12/31/20205,687220383798N/A
9/30/20205,893-531381948N/A
6/30/20205,915-594213808N/A
3/31/20205,9131121591N/A
12/31/20196,00734-193611N/A
9/30/20196,276965-419666N/A
6/30/20196,4361,160-779683N/A
3/31/20196,471697-910738N/A
12/31/20186,337804-702735N/A
9/30/20186,207871-889321N/A
6/30/20185,990864N/A597N/A
3/31/20185,725852N/A748N/A
12/31/20175,373830N/A639N/A
9/30/20175,021907N/A1,004N/A
6/30/20174,8331,081N/A867N/A
3/31/20174,6471,205N/A904N/A
12/31/20164,4471,250N/A1,071N/A
9/30/20164,1431,189N/A908N/A
6/30/20163,7511,095N/A998N/A
3/31/20163,346942N/A810N/A
12/31/20152,932831N/A718N/A
9/30/20152,555736N/A689N/A
6/30/20152,273613N/A642N/A
3/31/20152,049534N/A532N/A
12/31/20141,911484N/A522N/A
9/30/20141,772409N/A417N/A
6/30/20141,579375N/A327N/A
3/31/20141,381296N/A295N/A
12/31/20131,205237N/A276N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei 300017 ( 13.8% per jaar) ligt boven de spaarquote ( 2.8% ).

Winst versus markt: De winst van 300017 ( 13.8% per jaar) zal naar verwachting langzamer groeien dan de markt CN ( 26.3% per jaar).

Hoge groeiwinsten: De winst van 300017 zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van 300017 ( 7.8% per jaar) zal naar verwachting langzamer groeien dan de markt CN ( 13.9% per jaar).

Hoge groei-inkomsten: De omzet van 300017 ( 7.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen 300017 zal naar verwachting over 3 jaar laag zijn ( 7.3 %).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y